Latest in News & Research

Study Compares Biologics for Long-Term Treatment of Psoriasis

Adjusted survival curves from the multivariable model for effectiveness showed higher drug survival for guselkumab

By Dermsquared Editorial Team | | July 06, 2022

Skindex-Mini Can Play Role in ID'ing Pediatric Eczema Severity

Based on validated IGA, EASI, POEM, and CDLQI, the Skindex-Mini Total score could distinguish atopic dermatitis severity

By Dermsquared Editorial Team | | July 06, 2022

Many Gen Z Americans Have Sun Safety All Wrong

You might think everyone knows by now to protect against the sun's rays, but many Gen Zers apparently haven't gotten the message.

In a...

By Physician's Briefing Staff | | July 06, 2022

Rise in Cost of Biologics for Psoriasis Outpacing Medical Inflation

Apart from secukinumab, the mean cost of biologics increased by >100 percent than inflation alone would explain

By Physician’s Briefing Staff | | July 05, 2022

Twelve-Week Treatment Regimen Reduces Facial Redness

Skin seemed less inflamed, improvement seen in overall skin appearance, and skin looked and felt healthier

By Physician’s Briefing Staff | | July 01, 2022

What Factors Are Associated With the Burden of Atopic Dermatitis?

Atopic dermatitis severity and time spent managing symptoms have the strongest associations with disease burden

By Dermsquared Editorial Team | | June 29, 2022

Is Mohs Micrographic Surgery Beneficial for High-Risk cSCC?

Mohs yields high five-year disease specific survival, local recurrence-free survival, and regional/distant metastasis-free survival

By Dermsquared Editorial Team | | June 29, 2022

Experts Address Lab Monitoring of Isotretinoin for Treating Acne

Consensus reached on recommendations to test alanine aminotransferase, triglycerides within a month prior to initiation and at peak dose

By Physician’s Briefing Staff | | June 29, 2022

Should Secukinumab Dosing for Psoriasis Be Adjusted for Patient Weight?

PASI 90 responses significantly higher for secukinumab 300 mg every two weeks versus every four weeks for patients weighing ≥90 kg

By Dermsquared Editorial Team | | June 22, 2022

Two Patient-Reported Outcome Measures Useful for Determining QoL With Acne

Systematic review finds that Acne-Q and CompAQ can be used for measuring acne-associated quality of life

By Dermsquared Editorial Team | | June 22, 2022

Prevalence of Metabolic Syndrome 32 Percent in Psoriasis Patients

Patients with psoriasis vulgaris or severe psoriasis had higher prevalence of MetS compared with other types

By Physician’s Briefing Staff | | June 22, 2022

Tiny Mites Are Feeding on Your Skin, But for How Long?

Survey shows lack of knowledge may lead to behaviors that contribute to sun damage, skin cancer

By Dennis Thompson (HealthDay News) | | June 22, 2022

Predictors of Diagnostic Delay in Psoriasis Identified

Male patients have longer diagnostic delay than female patients; longer diagnostic delay seen for those with psoriasis in specific areas

By Physician’s Briefing Staff | | June 21, 2022

Study Compares Baricitinib to Dexamethasone for COVID-19

Baricitinib plus remdesivir shows similar efficacy but better safety profile than dexamethasone plus remdesivir in hospitalized adults

By Physician’s Briefing Staff | | June 21, 2022

Skin Tags? Moles? Products Promising to Treat Them Can Do Real Harm

It may seem tempting to remove a mole or skin tag you don't like with a product that promises to make them disappear quickly.

...

By Cara Murez (HealthDay News) | | June 20, 2022

Diffuse Reflectance Spectroscopy Can Help Assess Psoriasis Severity

Mexameter erythema readings are a good representation of skin oxygenated hemoglobin, but not deoxygenated hemoglobin

By Physician's Briefing Staff | | June 16, 2022

Immediate, Delayed Reactions to Fragrances ID'd in Thai Population

Cinnamic aldehyde and cinnamic alcohol were most frequently encountered substances in immediate, delayed reactions

By Dermsquared Editorial Team | | June 15, 2022

Lichen Sclerosus Linked to Depression, Anxiety in Adult Women

Lichen sclerosus remained significantly associated with depression and anxiety in multivariable analyses

By Dermsquared Editorial Team | | June 15, 2022

Global Seroprevalence of Tickborne Lyme Disease About 14.5 Percent

Factors associated with Bb seropositivity include male sex, age ≥50 years, residence in rural areas, suffering tick bites

By Physician's Briefing Staff | | June 14, 2022

FDA Approves First Pill to Treat Severe Alopecia Areata

Olumiant is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot

By Physician’s Briefing Staff | | June 14, 2022

Higher Fish Intake May Increase Melanoma Risk

Higher total fish intake, tuna intake, nonfried fish intake positively linked to risks of malignant melanoma, melanoma in situ

By Physician's Briefing Staff | | June 10, 2022

Tretinoin Precursors, Tretinoin Work Similarly for Facial Photodamage

MMP2 mRNA was significantly reduced in TTP-treated samples; changes in MMP2 were associated with changes in fine wrinkles

By Dermsquared Editorial Team | | June 08, 2022

Alopecia Areata Symptom Impact Scale Tied to Disease Severity, Response

Alopecia Areata Quality of Life Index showed no correlation with AA severity pretreatment or posttreatment

By Dermsquared Editorial Team | | June 08, 2022

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026